Abstract:OBJECTIVE:To investigate the activation pattern of signal transducers and activators of transcription (STAT) induced by vascular endothelial growth factor (VEGF) in CD34+ hematopoietic progenitor cells, and gain an insight into the molecular mechanism and signal transduction pathway of VEGF that has an effect on CD34+ hematopoietic progenitor cells.METHODS:After isolated from umbilical cord blood by using a high-gradient magnetically activated cell sorting system (MACS), CD34+ cells were stimulated by VEGF (50 ng/ml) for different time (0, 15, 30, 45, 60, 90 min) to detect the tyrosine phosphorylation and nuclear translocation of STAT-3 and STAT-5 with Western blot and immunocytochemistry methods. The expression of VEGF receptor-2 (VEGFR2) on the membrane of CD34+ progenitor cells was examined by immunocytochemistry. ATWLPPR, an effective peptide screened from phage epitope library by affinity for membrane-expressed VEGFR2 and blocking the binding of VEGF to VEGFR2, was used to determine whether the activation of STAT pathway induced by VEGF was blocked.RESULTS:Tyrosine phosphorylation of STAT-3 and STAT-5 was undetectable in unstimulated CD34+ cells, but was evident at 15 min in response to VEGF stimulation. VEGF resulted in a rapid and transient tyrosine phosphorylation of STAT-3 and STAT-5. The maximal tyrosine phosphorylation was catched at 30 and 45 min, respectively (P = 0.0001), and returned to basal levels at 90 min. Immunocytochemistry confirmed that increased phosphorylated STAT-3 was translocated into the nuclei at 30 min (P = 0.0001), and mainly in cytoplasms again at 90 min after stimulation with VEGF. However, compared with unstimulated CD34+ cells, there was only increased phosphorylation of STAT-5 appeared mainly in cytoplasms, but no significant nuclear translocation was found after stimulation with VEGF (P > 0.05). The presence of VEGFR2 was confirmed using anti-VEGFR2 antibody staining by immunocytochemistry, moreover, the phosphorylation of STAT-3 and STAT-5 failed to be activated by the co-culture with ATWLPPR and VEGF, suggesting that activation of the STAT pathway be specifically mediated by VEGFR2 in CD34+ progenitor cells.CONCLUSIONS:STAT signaling pathway participates in the signal transduction of VEGF via VEGFR2 in CD34+ hemopoietic progenitor cells.

Cloning and expression of truncated KDR binding to vascular endothelial growth factor

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

Expression of VEGF Receptor KDR in Different Originated Carcinomas

Cloning of human vascular endothelial growth factor cDNA and its expression in COS-7 cells

Application of Homologous Recombination in Vitro to Construct Pcdna3.1-Ngf and Pcdna3.1-Trka

Molecular Cloning, Expression And Characterization Of Recombinant Human Vascular Endothelial Growth Factor 121

Gene cloning of secreted VEGF receptor flt-1 (I similar to IV extracellular domain) and the corresponding recombinant adenovirus construction and expression

Cloning Rat BDNF Gene and Construction of a Recombinant Retroviral Vector Plxsn-Bdnf

[Cloning of Transmembrane Domain Sequence of EGFR Gene]

Inhibition of monoclonal antibodies against extracellular I-IV domains of vascular endothelial cell growth factor receptor KDR on the proliferation EC and formation of chicken embryo blood vessels

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications

Expression of VEGFR2 Ligand Binding Domain in Pichia pinkTM 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain

Cloning and expression of a novel target fusion protein and its application in anti-tumor therapy

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Screening and Characterization of Inhibiting Peptides Binding to the Tumor Vascular Growth Factor Receptor

[Application of Polytetrafluoroethylene As VEGF Gene Carrier].

Cloning of a Full Length cDNA of Human Thrombopoietin Receptor c-Mpl and Construction of Engineered Cells that Stably Express c-mpl

[Gene Expression and Primary Functional Characterization of Human DR5 Extracellular Fragment].

Expression of human vascular endothelial growth factor receptor Flt-1 extracellular domain 1-3 loop cDNA in Pichia pastoris, purification of the expressed product and detection of its biological activity.

Coexpression of vascular endothelial growth factor and its receptor KDR on gastric adenocarcinoma MGC803 cell line and stimulation of exogenous VEGF 165 to MGC803 cells